Cargando…

Depression in type 1 diabetes was associated with high levels of circulating galectin-3

OBJECTIVE: Neuroinflammatory responses are implicated in depression. The aim was to explore whether depression in patients with type 1 diabetes (T1D) was associated with high circulating galectin-3, controlling for metabolic variables, s-creatinine, life style factors, medication and cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melin, Eva Olga, Dereke, Jonatan, Thunander, Maria, Hillman, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000756/ https://www.ncbi.nlm.nih.gov/pubmed/29760188 http://dx.doi.org/10.1530/EC-18-0108

Ejemplares similares

Soluble CD163 was linked to galectin-3, diabetic retinopathy and antidepressants in type 1 diabetes
por: Melin, Eva O, et al.
Publicado: (2018)

Female sex, high soluble CD163, and low HDL-cholesterol were associated with high galectin-3 binding protein in type 1 diabetes
por: Melin, Eva Olga, et al.
Publicado: (2019)

Galectin-3, metalloproteinase-2 and cardiovascular disease were independently associated with metalloproteinase-14 in patients with type 1 diabetes: a cross sectional study
por: Melin, Eva Olga, et al.
Publicado: (2021)

Galectin-3 Binding Protein, Depression, and Younger Age Were Independently Associated With Alexithymia in Adult Patients With Type 1 Diabetes
por: Melin, Eva O., et al.
Publicado: (2021)

Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes: a cross-sectional study
por: Melin, Eva O., et al.
Publicado: (2020)

Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
por: Melin, Eva O., et al.
Publicado: (2020)

A comparison in women with newly diagnosed diabetes between those with and without a history of gestational diabetes: a new perspective
por: Stogianni, Anna, et al.
Publicado: (2023)

Midnight salivary cortisol secretion and the use of antidepressants were associated with abdominal obesity in women with type 1 diabetes: a cross sectional study
por: Melin, Eva Olga, et al.
Publicado: (2019)

Depression, smoking, physical inactivity and season independently associated with midnight salivary cortisol in type 1 diabetes
por: Melin, Eva O, et al.
Publicado: (2014)

Depression differed by midnight cortisol secretion, alexithymia and anxiety between diabetes types: a cross sectional comparison
por: Melin, Eva O., et al.
Publicado: (2017)

Lower HDL-cholesterol, a known marker of cardiovascular risk, was associated with depression in type 1 diabetes: a cross sectional study
por: Melin, Eva Olga, et al.
Publicado: (2019)

Plasma Levels of the Interleukin-1-Receptor Antagonist Are Lower in Women with Gestational Diabetes Mellitus and Are Particularly Associated with Postpartum Development of Type 2 Diabetes
por: Katra, Pernilla, et al.
Publicado: (2016)

Abdominal obesity in type 1 diabetes associated with gender, cardiovascular risk factors and complications, and difficulties achieving treatment targets: a cross sectional study at a secondary care diabetes clinic
por: Melin, Eva O., et al.
Publicado: (2018)

HbA1c levels and circulating inflammatory proteins at onset of type 1 diabetes in children and adolescents
por: Dereke, Jonatan, et al.
Publicado: (2022)

Gender, alexithymia and physical inactivity associated with abdominal obesity in type 1 diabetes mellitus: a cross sectional study at a secondary care hospital diabetes clinic
por: Melin, Eva O., et al.
Publicado: (2017)

Midnight salivary cortisol secretion associated with high systolic blood pressure in type 1 diabetes
por: Melin, Eva Olga, et al.
Publicado: (2019)

Depression was associated with younger age, female sex, obesity, smoking, and physical inactivity, in 1027 patients with newly diagnosed type 2 diabetes: a Swedish multicentre cross-sectional study
por: Melin, Eva O., et al.
Publicado: (2022)

Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15–34 years of age: a prospective cohort study
por: Samuelsson, My, et al.
Publicado: (2017)

Does a gluten-free diet lead to better glycemic control in children with type 1 diabetes? Results from a feasibility study and recommendations for future trials
por: Söderström, Hanna, et al.
Publicado: (2022)

Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance
por: Dereke, Jonatan, et al.
Publicado: (2019)

Soluble CD163 and glycated haemoglobin were independently associated with the progression of diabetic retinopathy in adult patients with type 1 diabetes
por: Hector, Sven, et al.
Publicado: (2023)

Circulating Galectin-3 levels and Diabetic Nephropathy: a systematic review and meta-analysis
por: Guo, Yong, et al.
Publicado: (2023)

Correction to: Circulating galectin-3 levels and diabetic nephropathy: a systematic review and meta-analysis
por: Guo, Yong, et al.
Publicado: (2023)

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
por: Nguyen, My-Nhan, et al.
Publicado: (2018)

Genetic determinants of circulating galectin‐3 levels in patients with coronary artery disease
por: Liao, Yu‐Huang, et al.
Publicado: (2020)

Impact of Galectin-3 Circulating Levels on Frailty in Elderly Patients with Systolic Heart Failure
por: Komici, Klara, et al.
Publicado: (2020)

Clinical Implication of Elevated Circulating Galectin-3 Level on Predicting the Occurrence of Ventricular Arrhythmias
por: Nakagawa, Yuri, et al.
Publicado: (2022)

Circulating Galectin‐3 Is Associated With Cardiometabolic Disease in the Community
por: Nayor, Matthew, et al.
Publicado: (2015)

Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment
por: Sundblad, Victoria, et al.
Publicado: (2021)

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke
por: He, Xin-Wei, et al.
Publicado: (2017)

A Genome-Wide Association Study of Circulating Galectin-3
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin‐3 level
por: Ma, Shizhan, et al.
Publicado: (2020)

Galectin-1 in Obesity and Type 2 Diabetes
por: Fryk, Emanuel, et al.
Publicado: (2022)

Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer
por: Blair, Bailey B., et al.
Publicado: (2021)

The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
por: Barut, Zerrin, et al.
Publicado: (2023)

High blood galectin-3 level associated with risk of frailty in aging
por: Ji, Xueying, et al.
Publicado: (2023)

Circulating Galectin-3 Evaluation in Dogs With Cardiac and Non-cardiac Diseases
por: Lee, Ga-Won, et al.
Publicado: (2021)

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis
por: Duckworth, Carrie A., et al.
Publicado: (2015)

Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
por: Nygren, David, et al.
Publicado: (2022)

Serum galectin-3 levels are decreased in schizophrenia
por: Kiliç, Faruk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rb9dgfjif7himdec135e7uc0aa